NDC 80425-0275-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0275
- Requested NDC
- 80425-0275-01
- Package NDCs from labels
- 80425-0275-1, 80425-0275-2, 80425-0275-3, 80425-0275-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0275-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 80425-0275-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 80425-0275-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0275 | METHOCARBAMOL TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f4e98f9f-b20b-8608-e053-2a95a90aa6b0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0275-1 | EA - Each | 80425-0275 | b6c967f2-98bc-42ec-ab4a-6bc71b24ff32 | 1 | 2023-04-07 |
| 80425-0275-2 | EA - Each | 80425-0275 | 7d338d99-78ed-44e0-aad6-f1fc6ca6a7ca | 1 | 2023-04-07 |
| 80425-0275-3 | EA - Each | 80425-0275 | bc5e16c5-6c10-4d9c-bd86-cbbd5ded4871 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2026-11-06 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Doc Rx | 5e55526f-bb34-4b67-85ea-b2765e8066bb | 2026-11-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-11-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2026-11-04 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6ca768bf-5095-4148-82d2-a0c2dec16d87 | 2026-11-03 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | American Health Packaging | 1b5afc6c-e09c-41bd-8b7e-d12051b33a4b | 2026-10-29 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d8e3f8dc-9751-419b-8601-d85c43415c82 | 2026-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 2026-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | REGIMED MEDICAL | d4433a71-5cf9-4a32-8902-1c522f1a9acd | 2026-10-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules India Ltd | 42c0a177-7d62-4bcf-9fce-7dd484cda4d5 | 2026-10-07 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | Henry Schein, Inc | d48d76af-b55a-4908-95ff-e7de615c0513 | 2026-10-05 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | ASCLEMED USA INC. | 077fa923-bee0-4b34-a52d-6f870bcb4828 | 2026-09-29 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | 7dafab15-db4c-4425-b1a2-e56433ecccf6 | 2026-09-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | d0acdf52-e1a9-4489-91e1-ef434d311613 | 2026-09-23 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | e5fe4627-11cb-4ebd-8eb0-9be807446fdf | 2026-09-23 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | St. Mary's Medical Park Pharmacy | 5bc70fe6-67a6-795b-e063-6394a90a1193 | 2026-09-17 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 5b9b48e2-4ff4-3ceb-e063-6394a90a0499 | 2026-09-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 3e4c88fe-bc3d-463f-973c-e52062e4d4ba | 2026-09-14 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | REMEDYREPACK INC. | 87ff444e-d502-428c-8be7-89d36c0cf709 | 2026-09-11 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 5a585c87-6361-420d-e063-6294a90a1838 | 2026-08-31 | Warnings, Adverse reactions | 197944 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.